drugset / Trial / NCT02991781
Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation
Completed
106 enrolled
Aristotle University Of Thessaloniki
AAI Scientific Cultural Services Ltd (AAISCS) · collabNATIONAL ASSOCIATION OF GENERAL PRACTITIONERS IN BULGARIA · collab
RandomizedParallel-groupOpen-labelHealth-services research
Summary
This study will develop and experimentally test the efficiency of a neurofeedback training protocol vs. varenicline use for smoking cessation.
Timeline
- Start
- 2017-01
- Primary completion
- 2019-06
- Completion
- 2019-06
Publications
- Background Bamidis PD, Paraskevopoulos E, Konstantinidis E, Spachos D, Billis A. Multimodal e-Health Services for Smoking Cessation and Public Health: The SmokeFreeBrain Project Approach. Stud Health Technol Inform. 2017;245:5-9.
- Pandria N, Athanasiou A, Styliadis C, Terzopoulos N, Mitsopoulos K, Paraskevopoulos E, Karagianni M, Pataka A, Kourtidou-Papadeli C, Makedou K, Iliadis S, Lymperaki E, Nimatoudis I, Argyropoulou-Pataka P, Bamidis PD. Does combined training of biofeedback and neurofeedback affect smoking status, behavior, and longitudinal brain plasticity? Front Behav Neurosci. 2023 Jan 27;17:1096122. doi: 10.3389/fnbeh.2023.1096122. eCollection 2023.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varenicline | Small molecule | 1 mg | — |